Mutual of America Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Mutual of America Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-15,528	Closed	-$2.51M	–	1669
2021 Q2	$2.51M	Sell	15,528 -14,019	-47%	-$2.25M	0.02%	892
2021 Q1	$5.06M	Sell	29,547 -205	-0.7%	-$40.6K	0.05%	492
2020 Q4	$6.54M	Buy	29,752 +9,367	+46%	+$2.03M	0.07%	335
2020 Q3	$3.38M	Sell	20,385 -2,650	-12%	-$363K	0.05%	558
2020 Q2	$2.63M	Buy	+23,035	New	+$2.23M	0.04%	696

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Mutual of America Capital Management's MRTX Position: Q3 2021 in Review

Mutual of America Capital Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2021, closing a stake of 15,528 shares — an estimated $2.51M sold.

Mutual of America Capital Management first reported a position in MRTX in Q2 2020 and held it in 5 quarters. The position peaked at $6.54M in Q4 2020. 238 funds tracked by Wall St. Rank hold MRTX as of Q3 2021.

Mutual of America Capital Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Mutual of America Capital Management sold 15,528 Mirati Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $2.51M.
Mutual of America Capital Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
Mutual of America Capital Management's Mirati Therapeutics, Inc. Common Stock position peaked at $6.54M in Q4 2020.
238 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Mutual of America Capital Management's 13F filing for Q3 2021, filed 10 Nov 2021.